Inventor
IP STEPHEN H
US26 patents
⚠️ This page may combine multiple inventors who share the name “IP STEPHEN H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
T CELL SCIENCES INC
13 patentsUS5436319AJul 25, 1995
Cell free T cell antigen receptor beta chain and its clinical utilities
T CELL SCIENCES INC81 citations96
US5223426AJun 29, 1993
Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor
T CELL SCIENCES INC64 citations94
US5185250AFeb 9, 1993
Human γ, δT cell antigen receptor polypeptides and nucleic acids
T CELL SCIENCES INC26 citations92
US4845026AJul 4, 1989
Assay systems for detecting cell-free T cell antigen receptor related molecules and the clinical utilities of the assays
T CELL SCIENCES INC32 citations92
US5173499ADec 22, 1992
Compounds which inhibit complement and/or suppress immune activity
T CELL SCIENCES INC14 citations79
US5601822AFeb 11, 1997
γ, δ T cell receptor and methods for detection
T CELL SCIENCES INC8 citations73
US5340921AAug 23, 1994
Γ, δT cell receptor and methods and detection
T CELL SCIENCES INC9 citations73
US5260223ANov 9, 1993
Methods for detection of human gamma, γ T cell receptor
T CELL SCIENCES INC18 citations73
US5024940AJun 18, 1991
Nucleic acids encoding the delta chain of the T cell antigen receptor
T CELL SCIENCES INC15 citations73
US5808109ASep 15, 1998
Compounds that inhibit complement and/or suppress immune activity
T CELL SCIENCES INC11 citations71
US5506247AApr 9, 1996
Compounds that inhibit complement and/or suppress immune activity
T CELL SCIENCES INC11 citations71
US5366986ANov 22, 1994
Compounds which inhibit complement and/or suppress immune activity
T CELL SCIENCES INC9 citations71
US5401767AMar 28, 1995
Compounds which inhibit complement and/or suppress immune activity
T CELL SCIENCES INC3 citations60
UNIV JOHNS HOPKINS
5 patentsUS5981481ANov 9, 1999
Human C3b/C4b receptor (CR1)
UNIV JOHNS HOPKINS80 citations95
US5856297AJan 5, 1999
Human C3b/C4b receptor (CR1)
UNIV JOHNS HOPKINS58 citations95
US5472939ADec 5, 1995
Method of treating complement mediated disorders
UNIV JOHNS HOPKINS70 citations95
US5256642AOct 26, 1993
Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
UNIV JOHNS HOPKINS49 citations95
US5212071AMay 18, 1993
Nucleic acids encoding a human C3b/C4b receptor (CR1)
UNIV JOHNS HOPKINS100 citations95
ASTRA AB
5 patentsUS6171799B1Jan 9, 2001
Monoclonal antibodies reactive with defined regions of the T cell antigen receptor
ASTRA AB23 citations91
US5980892ANov 9, 1999
Monoclonal antibodies reactive with defined regions of the T cell antigen receptor
ASTRA AB17 citations91
US6048526AApr 11, 2000
Monoclonal antibodies reactive with defined regions of the T cell antigen receptor
ASTRA AB13 citations81
US5976533ANov 2, 1999
Monoclonal antibodies reactive with defined regions of the T cell antigen receptor
ASTRA AB4 citations72
US6313263B1Nov 6, 2001
γ, δ T cell receptor and methods for detection
ASTRA AB0 citations48